Oncolytics Biotech Director Bernd Seizinger Buys 100,000 Shares at $1.04/Share.

Oncolytics Biotech Inc. (ONCY) recently announced that Director Seizinger Bernd R. has made a significant investment in the company, acquiring 100,000 shares at a price of $1.04 per share on January 16, 2026. This strategic move highlights the company's potential for future growth and stability, and demonstrates Director Seizinger's confidence in Oncolytics Biotech's prospects. As a leading biotech firm, Oncolytics Biotech is focused on developing innovative treatments for various cancers, and this investment is a testament to the company's commitment to advancing its mission. With a strong and experienced leadership team, Oncolytics Biotech is well-positioned for long-term success and growth.